RUNX1 and acute myeloid leukemia: Ultimately, RUNX1-mutated paediatric AML did not show a distinct cytogenetic pattern, particularly with respect to the overlap with prognostically favourable subgroup CBF-AML, arguing against RUNX1 mutation as a distinct AML type in paediatrics.